Immune responses to cancer: are they potential biomarkers of prognosis?
Recent technical improvements in evaluations of immune cells in situ and immune monitoring of patients with cancer have provided a wealth of new data confirming that immune cells play a key role in human cancer progression. This, in turn, has revived the expectation that immune endpoints might serve...
Egile nagusia: | |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Frontiers Media S.A.
2013-05-01
|
Saila: | Frontiers in Oncology |
Gaiak: | |
Sarrera elektronikoa: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00107/full |